Lessee, Operating Lease, Liability, to be Paid of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Y-mAbs Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Jun 2025 was $4,446,000, a 223% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $4,446,000 +$3,071,000 +223% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $641,000 -$614,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $873,000 -$649,000 -43% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $1,151,000 -$601,000 -34% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $1,375,000 -$2,000 -0.14% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $1,255,000 -$389,000 -24% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,522,000 -$384,000 -20% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $1,752,000 -$625,000 -26% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,377,000 -$1,249,000 -48% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $1,644,000 -$1,689,000 -51% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $1,906,000 -$2,067,000 -52% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $2,377,000 -$354,000 -13% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $2,626,000 -$652,000 -20% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $3,333,000 -$484,000 -13% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $3,973,000 -$404,000 -9.2% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,731,000 -$2,169,000 -44% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $3,278,000 +$887,000 +37% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,817,000 +$1,249,000 +49% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $4,377,000 +$1,613,000 +58% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $4,900,000 +$1,950,000 +66% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,391,000 -$768,000 -24% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $2,568,000 -$778,000 -23% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $2,764,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,950,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $3,159,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $3,346,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.